Meet Dr. Quesada
Board-certified cardiologist and internal medicine doctor. with advanced training from Harvard, UCLA, and the Mayo Clinic, and staff cardiologist at Cedars-Sinai Medical Center.
%201.png)
%201.png)
%201.png)
%201.png)
Carlos Quesada, MD,
MPH
Preventive Cardiology, Internal Medicine, Primary Care
Medicine
Dr. Quesada is a board-certified internal medicine physician and cardiologist with advanced training in interventional and structural cardiology. He has trained at some of the nation’s most prestigious institutions, including Harvard Medical School, Ronald Reagan UCLA Medical Center, and the Mayo Clinic, and holds a Master of Public Health from Harvard with additional training in global health.
He completed his residency in internal medicine and global health equity at Harvard Medical School/Brigham and Women’s Hospital, followed by a cardiology fellowship at Ronald Reagan UCLA Medical Center. He then pursued subspecialty training in interventional cardiology and structural cardiology at the Mayo Clinic.
Dr. Quesada is a staff cardiologist at Cedars-Sinai Medical Center, where he maintains admitting privileges and continues to provide care as part of the Cedars medical staff. He is fluent in English and Spanish.
Board Certifications
Dr. Quesada is board-certified across multiple specialties, ensuring the highest standards of cardiovascular care.
Internal Medicine
%201.svg){kind=icon}
Cardiovascular Disease
%201.png){kind=icon}
Echocardiography
Cardiac CT
%201.svg){kind=icon}
Vascular Imaging
Nuclear Cardiology
Trusted Care at
Cedars-Sinai
Dr. Quesada will complete his practice with Cardiovascular Medical Group on December 31, 2025. Starting January 2026, he will welcome patients at Beverly Hills Cardiovascular, remaining a staff cardiologist at Cedars-Sinai Medical Center with full admitting privileges.
Stay Connected During the Transition
Have questions or want to schedule care with Dr. Quesada? Use the options below to call, email, or request an appointment at his new Beverly Hills office beginning January 2026.
